NCT06956885View on ClinicalTrials.gov

Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

450

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2029

Study Completion Date

May 1, 2030

Conditions

Gout Chronic

Interventions

DRUG

Discontibuation of oral ULT

Patients will stop the ULT at D0. They will have an US scan to look for urate deposits at each visit.

DRUG

Maintenance of ULT

Patients will continue their ULT according to the recommendations of the Eular and French Society of Rheumatology, to maintain their SUA levels below 60 mg/l.

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER